ImmunityBio, Inc.
IBRX
$8.56
$0.354.26%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.03% | 40.69% | 38.58% | 31.93% | 29.09% |
| Total Depreciation and Amortization | -12.13% | -12.14% | -9.98% | -8.47% | -5.18% |
| Total Amortization of Deferred Charges | -99.56% | -79.73% | -62.59% | -53.20% | -46.72% |
| Total Other Non-Cash Items | 5,199.32% | -62.76% | -77.46% | -76.87% | -98.94% |
| Change in Net Operating Assets | -179.73% | -47.87% | -54.98% | -36.17% | -588.36% |
| Cash from Operations | 22.06% | 24.13% | 14.74% | 4.95% | -6.67% |
| Capital Expenditure | 44.16% | 60.30% | 54.50% | 71.18% | 77.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,624.06% | -2,414.24% | 182.42% | 200.18% | -4,800.00% |
| Cash from Investing | -1,123.26% | -825.52% | 162.54% | 147.75% | 59.81% |
| Total Debt Issued | -97.03% | -100.00% | -100.00% | -77.00% | -78.52% |
| Total Debt Repaid | -1,712.50% | 80.95% | 67.90% | 45.57% | 16.88% |
| Issuance of Common Stock | 110.71% | 395.24% | 156.23% | 128.68% | 72.29% |
| Repurchase of Common Stock | 58.55% | 60.19% | 64.46% | 59.73% | -58.73% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | 42.12% | 20.53% | -50.71% | -45.00% | -49.56% |
| Foreign Exchange rate Adjustments | 165.22% | 106.98% | 227.27% | 107.79% | 92.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.30% | 22.78% | -91.10% | -262.07% | -175.78% |